A trial of vitamin a therapy to facilitate ductal closure in premature infants

Journal of Pediatrics

Volumn 143, Issue 5, 2003, Pages 644-648

  Ravishankar, Chitra ^b   Nafday, Suhas ^b   Green, Robert S ^b   Kamenir, Steven ^b   Lorber, Richard ^b   Stacewicz Sapuntzakis, Maria ^b   Bridges, Nancy D ^b   Holzman, Ian R ^b   Gelb, Bruce D ^a  

^a Departments of Human Genetics and Pediatrics   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; RETINOL; RETINOL BINDING PROTEIN;

ARTERY LIGATION; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; ECHOCARDIOGRAPHY; GESTATIONAL AGE; HUMAN; INDWELLING CATHETER; NEWBORN; OXYGENATION; PATENT DUCTUS ARTERIOSUS; POSTNATAL CARE; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT FAILURE; VERY LOW BIRTH WEIGHT;

EID: 0344874212     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0022-3476(03)00501-8     Document Type: Article

References (21)

1. Cotton RB, Stahlman MT, Kovar I, Catterton WZ. Medical management of small preterm infants with symptomatic patent ductus arteriosus. J Pediatr 1978;92:467-73.
2. Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 1976;295:530-3.
3. Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE. Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med 1976;295:526-9.
4. Gersony WM, Peckham G, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus; results of a national collaborative study. J Pediatr 1983;102:895-906.
5. Fowlie PW. Intravenous indomethacin for preventing mortality and morbidity in very low birth weight infants (Cochrane Review). In The Cochrane Library, Issue 3, 1999. Oxford: Update Software.
6. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards D. Randomized double blind controlled trial comparing the effects of Ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 1999;47:36-42.
7. Kitterman JA, Edmunds LH, Gregory GA, Heymann MA, Tooley H, Rudolph AM. Patent ductus arteriosus in premature infants: incidence and relation to pulmonary disease and management. N Engl J Med 1972;287:473-7.
8. Mavroudis C, Cook LN, Fleischer JW, Nagaraj HS, Shott RJ, Howe WR, et al. Management of patent ductus arteriosus in the premature infant: indomethacin versus ligation. Ann Thorac Surg 1983;36:561-6.
9. Wagner HR, Ellison C, Zierler S, Lang P, Purohit DM, Behrendt D, et al. Surgical closure of patent ductus arteriosus in 268 preterm infants. J Thorac Cardiovasc Surg 1984;87:870-5.
10. Heymann MA, Rudolph AM. Control of the ductus arteriosus. Physiol Rev 1975;55:62-78.
11. Wilson JG, Warkany J. Aortic arch and cardiac anomalies in the offspring of vitamin A deficient rats. Anat J Anat 1949;85:113-55.
12. Colbert MC, Kirby ML, Robbins J. Endogenous retinoic acid signaling co-localizes with advanced expression of the adult smooth muscle heavy chain isoform during development of the ductus arteriosus. Circ Res 1996;78:790-798.
13. Momma K, Manatomo T, Miyagawa-Tomita S. Accelerated maturation of fetal ductus arteriosus by maternally administered vitamin A in rats. Pediatr Res 1998;43:629-32.
14. Wu G, Jing S, Momma K, Nakanishi T. The effect of vitamin A on contraction of the ductus arteriosus in fetal rat. Pediatr Res 2001;49:997-1002.
15. Shenai JP, Chytil F, Stahlman MT. Vitamin A status of neonates with bronchopulmonary dysplasia. Pediatr Res 1985;19:185-8.
16. Shenai JP, Kennedy KA, Chytil F, Stahlman MT. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr 1987;111:269-77.
17. Pearson E, Bose C, Snido T, Ransm L, Young T, Bose G, et al. Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. J Pediatr 1992;121:420-7.
18. Tyson JE, Wright LL, Oh W, Kennedy KA, Mele L, Ehrenkranz RA, et al. Vitamin A supplementation for extremely low birth infants. N Engl J Med 1999;340:1962-8.
19. Shenai JP. Vitamin A supplementation in very low birth weight neonates: rationale and evidence. Pediatrics 1999;104:1369-74.
20. Darlow BA, Graham PJ. Vitamin A supplementation for preventing morbidity and mortality in very low birth weight infants (Cochrane Review). In The Cochrane Library, Issue 1, 2002. Oxford: Update Software.
21. Bell MJ, Ternber JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Therapeutic decision based upon clinical staging. Ann Surg 1978;187:1-7.